Analysts Remain Optimistic in Sagimet Biosciences (SGMT)’s Outlook Following Q4 and Full-Year 2025 Results
On March 11, 2026, in its fourth-quarter and full-year 2025 financial results update, Sagimet Biosciences Inc.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Woodline Partners Michael Rockefeller And Karl Kroeker | 1,000,943 | $5,229,927 | 0.02% | |
| 2. | Marshall Wace LLP Paul Marshall And Ian Wace | 966,253 | $5,043,840 | +24% | 0.01% |
| 3. | Baker Bros. Advisors Julian Baker And Felix Baker | 952,996 | $4,979,404 | 0.03% | |
| 4. | Millennium Management Israel Englander | 862,303 | $4,505,533 | +47% | 0% |
| 5. | Hillhouse Capital Management Lei Zhang | 724,800 | $3,787,080 | 0.23% |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.27 | 12,100 | $63,730.70 | 639,200 | 2024-03-26 | Filing | |
| $4.10 | 1,600 | $6,560.00 | 627,100 | 2023-12-07 | Filing | |
| $2.35 | 590 | $1,386.50 | 590 | 2023-11-16 | Filing | |
| $16.00 | 30,000 | $480,000.00 | 3,850,275 | 2023-07-18 | Filing | |
| $16.00 | 46,875 | $750,000.00 | 46,875 | 2023-07-18 | Filing |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $7.76 | 64,051 | $497,067.79 | 741,570 | 2026-07-20 | Filing | |
| $7.76 | 10,545 | $81,832.36 | 224,414 | 2026-07-20 | Filing | |
| $7.46 | 18,844 | $140,529.13 | 62,161 | 2026-07-20 | Filing | |
| $5.36 | 12,101 | $64,864.99 | 677,621 | 2026-02-10 | Filing | |
| $5.36 | 1,312 | $7,032.71 | 15,688 | 2026-02-10 | Filing |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 66,414 | $513,380 | 0% | |
| 2. | 21,376 | $165,236 | 0% | |
| 3. | 18,064 | $139,635 | 0.02% | |
| 4. | 17,331 | $133,969 | 0% | |
| 5. | 14,100 | $108,993 | 0% |